Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
The COVID-19 pandemic has highlighted the importance of vaccines in controlling the epidemic in sub-Saharan Africa and a renewed interest in vaccine research and development across the country.
Read Full NewsLack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.
A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.
Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.
Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.
1.
Five-year survival in patients with unresectable hepatocellular carcinoma sets milestone
2.
Survey: Record Numbers of US Adults Report Depression.
3.
Increased Exercise May Lower the Risk of Prostate Cancer.
4.
Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation
5.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
1.
Oncolytic Vaccinia Virus Immunotherapy: A New Frontier in GI Cancer Treatment
2.
A Review of Cancer Treatment Evolution Towards Stem Cells and Gene Therapy
3.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
4.
Priming Agents: A Novel Approach to Enhancing Cell-Free DNA Detection in Liquid Biopsies
5.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
4.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
5.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge